Division of Pharmacy and Optometry, The University of Manchester, Manchester, UK
Retired, Patient and Public Involvement member, Manchester, UK.
Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e102-e108. doi: 10.1136/ejhpharm-2020-002365. Epub 2020 Dec 1.
To survey and explore current approaches to deployment of pharmaceutical care prioritisation tools in acute hospitals in the UK.
A national online survey was circulated electronically to chief pharmacists of hospitals to determine if they use a prioritisation tool or process. Where such mechanisms exist, respondents were invited to participate in a semistructured telephone interview to explore the development, evaluation and application of their tool and share relevant documentation. Interviews were transcribed and thematically analysed.
Seventy hospitals (70/130) used a tool or process to prioritise clinical pharmacy services. Thirty-six interviews were conducted, and two were excluded. The majority of tools had been developed in-house. Few hospitals had undertaken formal evaluations of their prioritisation tool. Pharmacy prioritisation tools ranged in complexity and often included a combination of pharmacy service prioritisation, such as medicines reconciliation, and a section to assign an individual patient prioritisation level. Determining the priority of a patient based on the identification of set indicators instilled confidence in pharmacists by ensuring they were not missing high-risk patients. Electronic prioritisation tools were especially useful at retrieving real-time data to prioritise workload, improving workflow and ensuring continuity in patient care. Drawbacks of using prioritisation tools included lack of tool sensitivity across certain specialties and time spent using the tool if not all information was accessible.
Prioritisation tools were seen to be useful for prioritising workload and ensuring the right patients are seen at the right time. As few hospitals had formally evaluated their tools, it is important to rigorously and systematically develop an evidence-based prioritisation tool that is both useable and acceptable. Further research to evaluate such tools would be needed to ensure it improves patient health outcomes and efficiency in pharmacy services.
调查和探索英国急性医院中药物治疗优先排序工具的使用现状。
对医院的首席药剂师进行了全国性的在线调查,以确定他们是否使用优先排序工具或流程。在存在此类机制的情况下,邀请受访者参加半结构化电话访谈,以探讨其工具的开发、评估和应用,并分享相关文件。对访谈进行了转录和主题分析。
70 家医院(130 家中的 70 家)使用工具或流程来优先安排临床药学服务。进行了 36 次访谈,排除了 2 次。大多数工具都是内部开发的。很少有医院对其优先排序工具进行了正式评估。药学优先排序工具的复杂程度各不相同,通常包括药学服务优先排序,如药物重整,以及为个别患者分配优先排序级别的部分。通过确定一系列指标来确定患者的优先级,这让药剂师有信心确保不会遗漏高风险患者。电子优先排序工具特别有助于检索实时数据以优先安排工作量,改善工作流程并确保患者护理的连续性。使用优先排序工具的缺点包括某些专业的工具敏感性不足,如果无法获得所有信息,则需要花费时间使用该工具。
优先排序工具被认为对于优先安排工作量和确保正确的患者在正确的时间得到治疗非常有用。由于很少有医院对其工具进行正式评估,因此重要的是要严格和系统地开发一种基于证据的优先排序工具,使其既实用又可接受。需要进一步研究此类工具,以确保其改善患者的健康结果并提高药学服务的效率。